The investigation of GABAergic systems in learning and extinction has principally focused on ionotropic GABA A receptors. Less well characterized is the metabotropic GABA B receptor, which when activated, induces a more sustained inhibitory effect and has been implicated in regulating oscillatory activity. Few studies have been carried out utilizing GABA B ligands in learning, and investigations of GABA B in extinction have primarily focused on interactions with drugs of abuse. The current study examined changes in GABA B receptor function using the GABA B agonist baclofen (2 mg/mL) or the GABA B antagonist phaclofen (0.3 mg/mL) on trace cued and contextual fear conditioning and extinction. The compounds were either administered during training and throughout extinction in Experiment 1, or starting 24 h after training and throughout extinction in Experiment 2. All drugs were administered 1 mL/kg via intraperitoneal injection. These studies demonstrated that the administration of baclofen during training and extinction trials impaired animals' ability to extinguish the fear association to the CS, whereas the animals that were administered baclofen starting 24 h after training (Experiment 2) did display some extinction. Further, contextual fear extinction was impaired by baclofen in both experiments. Tissue analyses suggest the cued fear extinction deficit may be related to changes in the GABA B2 receptor subunit in the amygdala. The data in the present investigation demonstrate that GABA B receptors play an important role in trace cued and contextual fear extinction, and may function differently than GABA A receptors in learning, memory, and extinction.
Introduction
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system and has been implicated in numerous forms of behavior (Baunez & Robbins, 1999; Kim & Richardson, 2007; Mohler, 2012; Wojnicki, Roberts, & Corwin, 2006) . GABAergic signaling is mediated through two distinct classes of GABA receptors, the ionotropic GABA A and GABA C receptors, which when activated produce a rapid and very shortlived inhibition via chloride current (Enna, 2007; Olsen, 2001; Watanabe, Maemura, Kanbara, Tamayama, & Hayasaki, 2002) , and the metabotropic GABA B receptor, which is responsible for a slow but sustained inhibitory current (Bettler, Kaupmann, Mosbacher, & Gassmann, 2004; Couve, Moss, & Pangalos, 2000) . The GABA B receptor is composed of two subunits, GABA B1 and GABA B2 . The GABA B1 subunit consists of two isoforms (GABA B1a and GABA B1b ) and binds GABA, as well as other ligands (Pinard, Seddik, & Bettler, 2010) . Research has suggested that GABA B receptors containing the GABA B1a subunit are primarily located presynaptically and those with GABA B1b subunits are primarily postsynaptic (Vigot et al., 2006) . However, this distribution may differ by brain region and whether the presynaptic neuron is GABAergic or glutamatergic (Waldmeier, Kaupmann, & Urwyler, 2008) . The GABA B2 subunit is responsible for binding to the intracellular G-protein, which produces presynaptic inhibition of calcium channels (Barral, Toro, Galarraga, & Bargas, 2000; Bussieres & El Manira, 1999) or postsynaptic activation of inward-rectifying potassium channels (Fernandez-Alacid et al., 2009) .
Considerable research investigating GABA systems in learning and memory has demonstrated that the administration of GABA A agonists produces impairments in acquisition (Baunez & Robbins, 1999) and consolidation (Castellano, Cabib, & Puglisi-Allegra, 1996; Chapouthier & Venault, 2002; Myhrer, 2003) , while GABA A antagonists and inverse agonists have been demonstrated to consistently enhance acquisition and consolidation in several learning and memory paradigms (Castellano et al., 1996; Chapouthier & Venault, 2002; Collinson, Atack, Laughton, Dawson, & Stephens, 2006; McNally, Augustyn, & Richardson, 2008; Myhrer, 2003) , including Pavlovian conditioning (Akirav, Raizel, & Maroun, 2006; McEown & Treit, 2010; Wilensky, Schafe, & LeDoux, 2000) . While
